These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32166311)

  • 1. It's Not Them, It's Us: Hepatitis C Reinfection Following Successful Treatment Among People Who Inject Drugs.
    Barocas JA
    Clin Infect Dis; 2021 Apr; 72(8):1401-1403. PubMed ID: 32166311
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis C Virus Reinfection Rate Among Persons Who Use Drugs and Are Maintained on Medication Treatment for Opioid Use Disorder.
    Springer SA
    Clin Infect Dis; 2020 Jun; 70(12):2703-2705. PubMed ID: 31346595
    [No Abstract]   [Full Text] [Related]  

  • 3. Reinfection Following Successful Direct-acting Antiviral Therapy for Hepatitis C Virus Infection Among People Who Inject Drugs.
    Cunningham EB; Hajarizadeh B; Amin J; Hellard M; Bruneau J; Feld JJ; Cooper C; Powis J; Litwin AH; Marks P; Dalgard O; Conway B; Moriggia A; Stedman C; Read P; Bruggmann P; Lacombe K; Dunlop A; Applegate TL; Matthews GV; Fraser C; Dore GJ; Grebely J
    Clin Infect Dis; 2021 Apr; 72(8):1392-1400. PubMed ID: 32166305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low Hepatitis C Reinfection Following Direct-acting Antiviral Therapy Among People Who Inject Drugs on Opioid Agonist Therapy.
    Akiyama MJ; Lipsey D; Heo M; Agyemang L; Norton BL; Hidalgo J; Lora K; Litwin AH
    Clin Infect Dis; 2020 Jun; 70(12):2695-2702. PubMed ID: 31346609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Phylogenetic Analysis of Hepatitis C Virus Transmission, Relapse, and Reinfection Among People Who Inject Drugs Receiving Opioid Agonist Therapy.
    Akiyama MJ; Lipsey D; Ganova-Raeva L; Punkova LT; Agyemang L; Sue A; Ramachandran S; Khudyakov Y; Litwin AH
    J Infect Dis; 2020 Jul; 222(3):488-498. PubMed ID: 32150621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C reinfection following successful direct-acting antiviral therapy among patients attending a multidisciplinary treatment centre for people who use drugs in Zurich, Switzerland.
    Falcato L; Bernardini C; Bruggmann P
    Int J Drug Policy; 2021 Oct; 96():103434. PubMed ID: 34511311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Call to Action: HCV Treatment of People Who Inject Drugs in the United States.
    Norton BL; Litwin AH
    Clin Infect Dis; 2020 May; 70(11):2366-2368. PubMed ID: 31513706
    [No Abstract]   [Full Text] [Related]  

  • 8. "Apparently, you can only be treated once": A qualitative study exploring perceptions of hepatitis C and access to treatment among people who inject drugs visiting a needle and syringe program.
    Fontaine G; Presseau J; Bruneau J; Patey AM; van Allen Z; Mortazhejri S; Høj SB; Hung JC; Grimshaw JM
    Int J Drug Policy; 2023 Nov; 121():104124. PubMed ID: 37451942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reinfection With the Hepatitis C Virus in Men Who Have Sex With Men After Successful Treatment With Direct-acting Antivirals in Germany: Current Incidence Rates, Compared With Rates During the Interferon Era.
    Ingiliz P; Wehmeyer MH; Boesecke C; Schulze Zur Wiesch J; Schewe K; Lutz T; Baumgarten A; Simon KG; Hueppe D; Rockstroh JK; Mauss S; Christensen S; ;
    Clin Infect Dis; 2020 Aug; 71(5):1248-1254. PubMed ID: 31562816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIV.
    Hosseini-Hooshyar S; Martinello M; Yee J; Read P; Baker D; Post JJ; Finlayson R; Bloch M; Doyle JS; Shaw D; Hellard M; Petoumenos K; Carson J; Dore GJ; Matthews GV;
    AIDS; 2020 Jul; 34(9):1347-1358. PubMed ID: 32590433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies to Reduce Hepatitis C Virus Reinfection in People Who Inject Drugs.
    Martinello M; Dore GJ; Matthews GV; Grebely J
    Infect Dis Clin North Am; 2018 Jun; 32(2):371-393. PubMed ID: 29778261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in hepatitis C elimination despite highly effective antiviral agents in patients with and without intravenous drug use.
    Bota S; Razpotnik M; Hucke F; Urak C; Flatscher K; Peck-Radosavljevic M
    Wien Klin Wochenschr; 2021 Jul; 133(13-14):641-646. PubMed ID: 34032930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More intensive hepatitis C virus care models promote adherence among people who inject drugs with active drug use: The PREVAIL study.
    Heo M; Pericot-Valverde I; Niu J; Norton BL; Akiyama MJ; Nahvi S; Arnsten JH; Litwin AH
    J Viral Hepat; 2023 Feb; 30(2):172-175. PubMed ID: 36197920
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of Chronic Hepatitis C in Patients Receiving Opioid Agonist Therapy: A Review of Best Practice.
    Norton BL; Akiyama MJ; Zamor PJ; Litwin AH
    Infect Dis Clin North Am; 2018 Jun; 32(2):347-370. PubMed ID: 29778260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Direct-acting Antivirals for Chronic Hepatitis C Virus Infection in People Who Inject Drugs or Receive Opioid Substitution Therapy: A Systematic Review and Meta-analysis.
    Graf C; Mücke MM; Dultz G; Peiffer KH; Kubesch A; Ingiliz P; Zeuzem S; Herrmann E; Vermehren J
    Clin Infect Dis; 2020 May; 70(11):2355-2365. PubMed ID: 31513710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alcohol Use Disorder and Hepatitis C Prevention and Care in People Who Inject Drugs: The State of Play.
    Marcellin F; Jaquet A; Lazarus JV; Molina P; Carrieri P
    Semin Liver Dis; 2021 May; 41(2):109-116. PubMed ID: 32851613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV).
    Fadnes LT; Aas CF; Vold JH; Ohldieck C; Leiva RA; Chalabianloo F; Skurtveit S; Lygren OJ; Dalgård O; Vickerman P; Midgard H; Løberg EM; Johansson KA;
    BMC Infect Dis; 2019 Nov; 19(1):943. PubMed ID: 31703669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus reinfection after successful treatment with direct-acting antiviral therapy in a large population-based cohort.
    Rossi C; Butt ZA; Wong S; Buxton JA; Islam N; Yu A; Darvishian M; Gilbert M; Wong J; Chapinal N; Binka M; Alvarez M; Tyndall MW; Krajden M; Janjua NZ;
    J Hepatol; 2018 Nov; 69(5):1007-1014. PubMed ID: 30142429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent Initiation of Hepatitis C and Opioid Use Disorder Treatment in People Who Inject Drugs.
    Rosenthal ES; Silk R; Mathur P; Gross C; Eyasu R; Nussdorf L; Hill K; Brokus C; D'Amore A; Sidique N; Bijole P; Jones M; Kier R; McCullough D; Sternberg D; Stafford K; Sun J; Masur H; Kottilil S; Kattakuzhy S
    Clin Infect Dis; 2020 Oct; 71(7):1715-1722. PubMed ID: 32009165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCV Cure and Reinfection Among People With HIV/HCV Coinfection and People Who Inject Drugs.
    Martinello M; Hajarizadeh B; Grebely J; Dore GJ; Matthews GV
    Curr HIV/AIDS Rep; 2017 Jun; 14(3):110-121. PubMed ID: 28432579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.